{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:21:45Z","timestamp":1792790505652,"version":"4.5.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T00:00:00Z","timestamp":1767312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100017415","name":"Peking University First Hospital","doi-asserted-by":"publisher","award":["2023IR07"],"award-info":[{"award-number":["2023IR07"]}],"id":[{"id":"10.13039\/100017415","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Glial fibrillary acidic protein astrocytopathy (GFAP-A) is a rare central nervous system (CNS) autoimmune disorder with highly heterogeneous presentations. This study aims to describe the clinical and diagnostic features in a Chinese case series.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Six patients at a single tertiary center with positive GFAP antibody were included, the patients\u2019 data were retrospectively analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The cohort included 3 males and 3 females, with a median age of 56 years (range 30\u201375). Prominent urinary dysfunction was observed in four patients (66.7%). Brain or spinal cord MRI abnormalities were present in only 50% (3\/6) of patients. All patients exhibited CSF-specific oligoclonal bands and elevated indices of intrathecal IgG synthesis. A notable finding was the delayed detection of CSF GFAP antibody in five patients (83.3%), who tested negative at disease onset but turned positive upon follow-up testing weeks to months later.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case series underscores the high frequency of autonomic urinary dysfunction and the potential for delayed antibody detection in Chinese GFAP-A patients. These findings suggest that clinical suspicion should remain high even with initial negative antibody testing, warranting repeat CSF analysis in suspected cases to avoid diagnostic delay.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12883-025-04606-6","type":"journal-article","created":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T05:40:38Z","timestamp":1767418838000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prominent urinary dysfunction and delayed antibody detection in patients with glial fibrillary acidic protein astrocytopathy: a case series analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Zhenyu","family":"Niu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunchuang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luhua","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiqiang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjun","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,2]]},"reference":[{"issue":"11","key":"4606_CR1","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1001\/jamaneurol.2016.2549","volume":"73","author":"B Fang","year":"2016","unstructured":"Fang B, McKeon A, Hinson SR, et al. Autoimmune glial fibrillary acidic protein astrocytopathy: a novel Meningoencephalo-myelitis. JAMA Neurol. 2016;73(11):1297\u2013307.","journal-title":"JAMA Neurol"},{"issue":"3","key":"4606_CR2","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41582-021-00616-3","volume":"18","author":"A Abdelhak","year":"2022","unstructured":"Abdelhak A, Foschi M, Abu-Rumeileh S, et al. Blood GFAP as an emerging biomarker in brain and spinal cord disorders. Nat Rev Neurol. 2022;18(3):158\u201372.","journal-title":"Nat Rev Neurol"},{"issue":"10","key":"4606_CR3","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.3174\/ajnr.A8236","volume":"45","author":"D Shetty","year":"2024","unstructured":"Shetty D, Brahmbhatt S, Desai A, et al. Glial fibrillary acidic protein astrocytopathy: review of pathogenesis, imaging features, and radiographic mimics. AJNR Am J Neuroradiol. 2024;45(10):1394\u2013402.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"9","key":"4606_CR4","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1002\/acn3.70118","volume":"12","author":"T Wu","year":"2025","unstructured":"Wu T, Zhang H, Gao C, et al. Glial fibrillary acidic protein astrocytopathy based on a two-center Chinese cohort study. Ann Clin Transl Neurol. 2025;12(9):1813\u201322.","journal-title":"Ann Clin Transl Neurol"},{"issue":"12","key":"4606_CR5","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.3390\/brainsci12121662","volume":"12","author":"L Liu","year":"2022","unstructured":"Liu L, Fang B, Qiao Z, et al. Clinical Manifestation, auxiliary examination features, and prognosis of GFAP autoimmunity: a Chinese cohort study. Brain Sci. 2022;12(12):1662.","journal-title":"Brain Sci"},{"issue":"7","key":"4606_CR6","doi-asserted-by":"publisher","first-page":"e16284","DOI":"10.1111\/ene.16284","volume":"31","author":"C Hagbohm","year":"2024","unstructured":"Hagbohm C, Ouellette R, Flanagan EP, et al. Clinical and neuroimaging phenotypes of autoimmune glial fibrillary acidic protein astrocytopathy: a systematic review and meta-analysis. Eur J Neurol. 2024;31(7):e16284.","journal-title":"Eur J Neurol"},{"key":"4606_CR7","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3389\/fneur.2018.00251","volume":"9","author":"X Yang","year":"2018","unstructured":"Yang X, Xu H, Ding M, et al. Overlapping autoimmune syndromes in patients with glial fibrillary acidic protein antibodies. Front Neurol. 2018;9:251.","journal-title":"Front Neurol"},{"issue":"9","key":"4606_CR8","doi-asserted-by":"publisher","first-page":"3054","DOI":"10.1161\/STROKEAHA.121.034480","volume":"52","author":"JL Saver","year":"2021","unstructured":"Saver JL, Chaisinanunkul N, Campbell BCV, et al. Standardized nomenclature for modified Rankin scale global disability outcomes: consensus recommendations from stroke therapy academic industry roundtable XI. Stroke. 2021;52(9):3054\u201362.","journal-title":"Stroke"},{"key":"4606_CR9","doi-asserted-by":"publisher","first-page":"1464891","DOI":"10.3389\/fneur.2024.1464891","volume":"15","author":"XK Wu","year":"2025","unstructured":"Wu XK, Zhai G, Zhang JR, et al. Clinical analysis and case series report on autoimmune glial fibrillary acidic protein astrocytopathy presenting with autonomic dysfunction. Front Neurol. 2025;15:1464891.","journal-title":"Front Neurol"},{"issue":"3","key":"4606_CR10","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/ene.13531","volume":"25","author":"Y Long","year":"2018","unstructured":"Long Y, Liang J, Xu H, et al. Autoimmune glial fibrillary acidic protein astrocytopathy in Chinese patients: a retrospective study. Eur J Neurol. 2018;25(3):477\u201383.","journal-title":"Eur J Neurol"},{"issue":"6","key":"4606_CR11","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s00415-025-13159-0","volume":"272","author":"J Arzalluz-Luque","year":"2025","unstructured":"Arzalluz-Luque J, Dumez P, Picard G, et al. Clinical course and long-term outcomes in autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy. J Neurol. 2025;272(6):421.","journal-title":"J Neurol"},{"issue":"3","key":"4606_CR12","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1002\/acn3.51513","volume":"9","author":"M Friedrich","year":"2022","unstructured":"Friedrich M, Hartig J, Pr\u00fcss H, Ip CW, Volkmann J. Rapidly progressive dementia: extending the spectrum of GFAP-astrocytopathies? Ann Clin Transl Neurol. 2022;9(3):410\u20135.","journal-title":"Ann Clin Transl Neurol"},{"issue":"s1","key":"4606_CR13","doi-asserted-by":"publisher","first-page":"S271","DOI":"10.3233\/JAD-179926","volume":"64","author":"H Zetterberg","year":"2018","unstructured":"Zetterberg H, Blennow K. From cerebrospinal fluid to blood: the third wave of fluid biomarkers for alzheimer\u2019s disease. J Alzheimers Dis. 2018;64(s1):S271\u20139.","journal-title":"J Alzheimers Dis"},{"key":"4606_CR14","doi-asserted-by":"publisher","first-page":"1136955","DOI":"10.3389\/fimmu.2023.1136955","volume":"14","author":"W Zhang","year":"2023","unstructured":"Zhang W, Xie Y, Wang Y, et al. Clinical characteristics and prognostic factors for short-term outcomes of autoimmune glial fibrillary acidic protein astrocytopathy: a retrospective analysis of 33 patients. Front Immunol. 2023;14:1136955.","journal-title":"Front Immunol"},{"key":"4606_CR15","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.3389\/fimmu.2018.02802","volume":"9","author":"F Shan","year":"2018","unstructured":"Shan F, Long Y, Qiu W. Autoimmune glial fibrillary acidic protein astrocytopathy: a review of the literature. Front Immunol. 2018;9:2802.","journal-title":"Front Immunol"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-025-04606-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04606-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04606-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T13:53:25Z","timestamp":1770040405000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12883-025-04606-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,2]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4606"],"URL":"https:\/\/doi.org\/10.1186\/s12883-025-04606-6","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,2]]},"assertion":[{"value":"6 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study is a retrospective analysis and has obtained the consent of each patient, was approved by the institutional review boards of Peking University First Hospital Ethics Committee.All of the research procedures involving human participants were in accordance with the Declaration of Helsinki. This article does not contain any research involving animals.All participants in this study were adults in the recovery phase of their illness at the time of providing informed consent. Their cognitive abilities were assessed through neuropsychological evaluations, confirming their capacity to ethically consent. The assessments were conducted and verified by a qualified neuropsychologist.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from all participants for the publication of their clinical details, examination results, and radiological images in the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"63"}}